Literature DB >> 9428549

Tissue protein synthesis rates in critically ill patients.

P Essén1, M A McNurlan, L Gamrin, K Hunter, G Calder, P J Garlick, J Wernerman.   

Abstract

OBJECTIVES: The aims of this study were to simultaneously determine the in vivo rates of protein synthesis in skeletal muscle, peripheral blood lymphocytes, and serum albumin in critically ill patients; to establish whether a relationship between the responses of these tissues could be observed; and to demonstrate if a protein synthesis pattern characteristic of critical illness exists.
DESIGN: Descriptive study.
SETTING: Intensive care unit of a 1000-bed university hospital. PATIENTS: Fifteen patients treated in the intensive care unit.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Rates of tissue protein synthesis were determined in vivo once during the course of critical illness, using the flooding method with L-(2H5)phenylalanine. Protein synthesis in muscle was 1.49 +/- 0.16%/day; in circulating lymphocytes (i.e., mononuclear cells), protein synthesis was 11.10 +/- 1.82%/day. Albumin synthesis was 12.81 +/- 1.23%/day when expressed as the fractional rate, and was 184 +/- 19 mg/kg/day when expressed as the absolute rate.
CONCLUSIONS: The individual tissues responded differently to trauma, and showed a wide range of values. The responses were not significantly correlated with each other and no pattern of tissue protein synthesis characteristic of critical illness was observed. However, both muscle protein and albumin synthesis rates correlated with metabolic status and clinical indices of the severity of illness.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9428549     DOI: 10.1097/00003246-199801000-00022

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  24 in total

1.  Leucine or carbohydrate supplementation reduces AMPK and eEF2 phosphorylation and extends postprandial muscle protein synthesis in rats.

Authors:  Gabriel J Wilson; Donald K Layman; Christopher J Moulton; Layne E Norton; Tracy G Anthony; Christopher G Proud; S Indu Rupassara; Peter J Garlick
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-09-13       Impact factor: 4.310

Review 2.  Intensive care unit-related generalized neuromuscular weakness due to critical illness polyneuropathy/myopathy in critically ill patients.

Authors:  Efstratios Apostolakis; Nikolaos A Papakonstantinou; Nikolaos G Baikoussis; George Papadopoulos
Journal:  J Anesth       Date:  2014-07-01       Impact factor: 2.078

3.  Sparing of muscle mass and function by passive loading in an experimental intensive care unit model.

Authors:  Guillaume Renaud; Monica Llano-Diez; Barbara Ravara; Luisa Gorza; Han-Zhong Feng; Jian-Ping Jin; Nicola Cacciani; Ann-Marie Gustafson; Julien Ochala; Rebeca Corpeno; Meishan Li; Yvette Hedström; G Charles Ford; K Sreekumaran Nair; Lars Larsson
Journal:  J Physiol       Date:  2012-12-24       Impact factor: 5.182

4.  Protein-sparing effect in skeletal muscle of growth hormone treatment in critically ill patients.

Authors:  L Gamrin; P Essén; E Hultman; M A McNurlan; P J Garlick; J Wernerman
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

Review 5.  Nutrition support for patients in the intensive care unit.

Authors:  R D Griffiths; T Bongers
Journal:  Postgrad Med J       Date:  2005-10       Impact factor: 2.401

6.  Novel events in the molecular regulation of muscle mass in critically ill patients.

Authors:  Despina Constantin; Justine McCullough; Ravi P Mahajan; Paul L Greenhaff
Journal:  J Physiol       Date:  2011-06-13       Impact factor: 5.182

Review 7.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

8.  Effects on skeletal muscle of intravenous glutamine supplementation to ICU patients.

Authors:  Inga Tjäder; Olav Rooyackers; Ann-Marie Forsberg; Rokhsareh F Vesali; Peter J Garlick; Jan Wernerman
Journal:  Intensive Care Med       Date:  2004-01-13       Impact factor: 17.440

Review 9.  Innate immune dysfunction in acute and chronic liver disease.

Authors:  Bettina Leber; Ursula Mayrhauser; Michael Rybczynski; Vanessa Stadlbauer
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

10.  Nutrition in Trauma and Critically Ill Patients.

Authors:  Bellal Joseph; Julie L Wynne; Stanley J Dudrick; Rifat Latifi
Journal:  Eur J Trauma Emerg Surg       Date:  2010-01-30       Impact factor: 3.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.